Akebia Therapeutics Newsroom

H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $7.5

Futu NewsOct 23 18:35

BTIG Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $5

Futu NewsOct 11 19:35

Akebia Therapeutics Analyst Ratings

BenzingaOct 11 01:24

Akebia Therapeutics Analyst Ratings

BenzingaOct 8 18:57

H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $7.5

Futu NewsOct 8 18:31

H.C. Wainwright Maintains Akebia Therapeutics(AKBA.US) With Buy Rating, Maintains Target Price $7.5

Futu NewsSep 6 18:31

Buy Rating Reaffirmed for Akebia Therapeutics Ahead of Vafseo's Market Launch

TipRanksSep 6 18:20

Akebia Therapeutics Analyst Ratings

BenzingaAug 12 19:04

Analysts Have Conflicting Sentiments on These Healthcare Companies: GeoVax Labs (GOVX), Akebia Therapeutics (AKBA) and Aveanna Healthcare Holdings (AVAH)

TipRanksAug 9 19:59

Buy Rating Justified by Akebia Therapeutics' Strengthened Dialysis Negotiations and Positive Commercial Prospects

TipRanksJul 12 20:17

Piper Sandler Sticks to Its Buy Rating for Akebia Therapeutics (AKBA)

TipRanksApr 26 19:56

Akebia Therapeutics Analyst Ratings

BenzingaMar 29 00:20

Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Akebia Therapeutics (AKBA) and Moderna (MRNA)

TipRanksMar 28 19:06

Analysts' Top Healthcare Picks: Verastem (VSTM), Akebia Therapeutics (AKBA)

TipRanksMar 17 00:35

Akebia Therapeutics Analyst Ratings

BenzingaMar 15 18:30

HC Wainwright & Co. Reiterates Buy on Akebia Therapeutics, Maintains $5 Price Target

BenzingaMar 15 18:30

BTIG Assumes Akebia Therapeutics at Buy, Announces Price Target of $4

BenzingaNov 29, 2023 20:31

Akebia Therapeutics Analyst Ratings

BenzingaNov 29, 2023 20:30

Akebia Therapeutics Analyst Ratings

BenzingaNov 17, 2023 20:06

Analysts Are Bullish on These Healthcare Stocks: Sensei Biotherapeutics (SNSE), Akebia Therapeutics (AKBA)

TipRanksNov 17, 2023 19:31